These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1720696)

  • 1. c-kit expression by CD34+ bone marrow progenitors and inhibition of response to recombinant human interleukin-3 following exposure to c-kit antisense oligonucleotides.
    Catlett JP; Leftwich JA; Westin EH; Grant S; Huff TF
    Blood; 1991 Dec; 78(12):3186-91. PubMed ID: 1720696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor alpha (TNF alpha) downregulates c-kit proto-oncogene product expression in normal and acute myeloid leukemia CD34+ cells via p55 TNF alpha receptors.
    Khoury E; Andre C; Pontvert-Delucq S; Drenou B; Baillou C; Guigon M; Najman A; Lemoine FM
    Blood; 1994 Oct; 84(8):2506-14. PubMed ID: 7522632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of adhesion molecules and c-kit on CD34+ hematopoietic progenitor cells: comparison of cytokine-mobilized blood stem cells with normal bone marrow and peripheral blood.
    Möhle R; Haas R; Hunstein W
    J Hematother; 1993; 2(4):483-9. PubMed ID: 7522108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines.
    Muszynski KW; Ruscetti FW; Gooya JM; Linnekin DM; Keller JR
    Stem Cells; 1997; 15(1):63-72. PubMed ID: 9007224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and physiologic significance of Kit ligand and stem cell tyrosine kinase-1 receptor ligand in normal human CD34+, c-Kit+ marrow cells.
    Ratajczak MZ; Kuczynski WI; Sokol DL; Moore JS; Pletcher CH; Gewirtz AM
    Blood; 1995 Sep; 86(6):2161-7. PubMed ID: 7545021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells.
    Muszynski KW; Ruscetti FW; Heidecker G; Rapp U; Troppmair J; Gooya JM; Keller JR
    J Exp Med; 1995 Jun; 181(6):2189-99. PubMed ID: 7539043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priming with recombinant human hematopoietic cytokines before bone marrow harvest expands in vivo and enhances ex vivo recovery of myeloid progenitors in short-term liquid cultures.
    Johnsen HE; Jensen L; Gaarsdal E; Hansen PB; Ersbøll J; Hansen NE
    Exp Hematol; 1994 Jan; 22(1):80-6. PubMed ID: 7506675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligodeoxynucleotides antisense to c-abl specifically inhibit entry into S-phase of CD34+ hematopoietic cells and their differentiation to granulocyte-macrophage progenitors.
    Rosti V; Bergamaschi G; Lucotti C; Danova M; Carlo-Stella C; Locatelli F; Tonon L; Mazzini G; Cazzola M
    Blood; 1995 Nov; 86(9):3387-93. PubMed ID: 7579442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
    Simmons PJ; Aylett GW; Niutta S; To LB; Juttner CA; Ashman LK
    Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
    To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
    Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early CD34high cells can be separated into KIThigh cells in which transforming growth factor-beta (TGF-beta) downmodulates c-kit and KITlow cells in which anti-TGF-beta upmodulates c-kit.
    Sansilvestri P; Cardoso AA; Batard P; Panterne B; Hatzfeld A; Lim B; Lévesque JP; Monier MN; Hatzfeld J
    Blood; 1995 Sep; 86(5):1729-35. PubMed ID: 7544639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13).
    Kirshenbaum AS; Goff JP; Semere T; Foster B; Scott LM; Metcalfe DD
    Blood; 1999 Oct; 94(7):2333-42. PubMed ID: 10498605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic actions of stem cell factor and other burst-promoting activities on proliferation of CD34+ highly purified blood progenitors expressing HLA-DR or different levels of c-kit protein.
    Sonoda Y; Sakabe H; Ohmisono Y; Tanimukai S; Yokota S; Nakagawa S; Clark SC; Abe T
    Blood; 1994 Dec; 84(12):4099-106. PubMed ID: 7527665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-10 increases Bcl-2 expression and survival in primary human CD34+ hematopoietic progenitor cells.
    Weber-Nordt RM; Henschler R; Schott E; Wehinger J; Behringer D; Mertelsmann R; Finke J
    Blood; 1996 Oct; 88(7):2549-58. PubMed ID: 8839847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of cord blood progenitors and use for hemopoietic reconstitution.
    Gabutti V; Timeus F; Ramenghi U; Crescenzio N; Marranca D; Miniero R; Cornaglia G; Bagnara GP
    Stem Cells; 1993 Jul; 11 Suppl 2():105-12. PubMed ID: 7691315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor on Fc gamma receptor expression and antibody-dependent cellular cytotoxicity of hematopoietic progenitor cells during in vitro myeloid maturation.
    Ericson SG; Benoit NE; Mills LE; Fanger MW
    Exp Hematol; 1994 Mar; 22(3):283-9. PubMed ID: 7509291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin- cells, and the generation of colony-forming cell progeny from CD34+lin- cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor.
    Bernstein ID; Andrews RG; Zsebo KM
    Blood; 1991 Jun; 77(11):2316-21. PubMed ID: 1710148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separation of myeloid and erythroid progenitors based on expression of CD34 and c-kit.
    De Jong MO; Wagemaker G; Wognum AW
    Blood; 1995 Dec; 86(11):4076-85. PubMed ID: 7492763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.